Table 3.
Score of randomized clinical trials with PEDro scale.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Migraine | |||||||||||
| Wei et al. (2022) | N | N | Y | N | N | N | N | N | Y | Y | 3/10 |
| Sacca et al. (2022) | Y | N | Y | N | N | N | N | N | Y | Y | 4/10 |
| Cao et al. (2021) | Y | N | Y | Y | N | N | Y | Y | Y | Y | 7/10 |
| Zhang et al. (2021) | Y | N | Y | Y | N | Y | N | Y | Y | Y | 7/10 |
| Luo et al. (2020) | Y | N | Y | Y | N | N | Y | N | Y | Y | 6/10 |
| Zhang et al. (2019) | N | Y | Y | Y | N | N | N | Y | Y | N | 5/10 |
| Straube et al. (2015) | Y | N | Y | Y | N | N | N | Y | Y | Y | 6/10 |
| Yang et al. (2014) | Y | N | N | Y | N | N | N | N | N | Y | 3/10 |
| Vijayalakshmi et al. (2014) | Y | N | N | N | N | N | N | N | N | N | 2/10 |
1: Random Allocation of Participants; 2: Concealed Allocation; 3: Similarity Between Groups at Baseline; 4: Participant Blinding; 5: Therapist Blinding; 6: Assessor Blinding; 7: Fewer than 15% Dropouts; 8: Intention- to-Treat Analysis; 9: Between- Group Statistical Comparisons; 10: Point Measures and Variability Data.
Y, Yes, If the criterion is satisfied.
N, No, If the criterion is not satisfied.